Drug interactions
Exenatide injectable + Insulin degludec-liraglutide
Severity: Major
Exenatide injectable and Insulin degludec-liraglutide: major interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Exenatide is a GLP-1 receptor agonist, and the combination product already contains liraglutide, so the two would duplicate therapy. Together they increase gastrointestinal adverse effects and the risk of hypoglycemia without added benefit.
What this interaction means in plain words
Exenatide injectable and Insulin degludec-liraglutide can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Why it happens
Therapeutic duplication of GLP-1 receptor agonism with additive glucose-lowering effects.
What to do
Avoid using two GLP-1 receptor agonists together. Use only one agent and adjust the insulin dose if switching.
What to ask your pharmacist
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Exenatide injectable and Insulin degludec-liraglutide, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Insulin degludec-liraglutide
Frequently asked questions
Can I take Exenatide injectable with Insulin degludec-liraglutide?
MediHelp rates the interaction as major. Exenatide injectable and Insulin degludec-liraglutide can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Exenatide is a GLP-1 receptor agonist, and the combination product already contains liraglutide, so the two would duplicate therapy. Together they increase gastrointestinal adverse effects and the risk of hypoglycemia without added benefit.
How serious is the interaction between Exenatide injectable and Insulin degludec-liraglutide?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid using two GLP-1 receptor agonists together. Use only one agent and adjust the insulin dose if switching.
What other medicines interact with Insulin degludec-liraglutide?
MediHelp also lists interactions of Insulin degludec-liraglutide with, for example, Albiglutide, Chlorpropamide, Clozapine. The full list is on the Insulin degludec-liraglutide page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
